Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial
Approved
Publication information
OKM publication type
A1
Category
Artikkelit ja abstraktit
Sub category
Tieteelliset aikakauslehtiartikkelit
Type
Alkuperäisartikkeli
Refereed
Kyllä
Publication channel information
Title of journal/series
Acta oncologica
Publication forum ID
50317
Country of publication
United Kingdom
Internationality
Yes
Detailed publication information
Publication year
2011
Journal/series volume number
50
Page numbers
344 - 352
Language of publication
English
Co-publication information
International co-publication
No
Classification and additional information
MinEdu field of science classification
3122 Cancers, 317 Pharmacy, 511 Economics